Return to study ST000981 main page

MB Sample ID: SA060000

Local Sample ID:160719cOEsa31_1
Subject ID:SU001020
Subject Type:Other
Subject Species:Felis catus
Taxonomy ID:9685
Age Or Age Range:5-10 years
Weight Or Weight Range:3.3-6.2 kg
Gender:Male and female

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU001020
Subject Type:Other
Subject Species:Felis catus
Taxonomy ID:9685
Age Or Age Range:5-10 years
Weight Or Weight Range:3.3-6.2 kg
Gender:Male and female

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
160719cOEsa31_1SA060000FL010554PlaceboGroup
160719cOEsa31_1SA060000FL010554Baseline (days 5-7)Timepoint
160719cOEsa31_1SA060000FL010554Male castratedGender
160719cOEsa31_1SA060000FL0105549Age at start of study (years)

Collection:

Collection ID:CO001014
Collection Summary:First-morning naturally-voided feces were collected daily on the last 3 days of baseline (days 5-7), treatment (26-28), and recovery (68-70)
Sample Type:Feces
Collection Method:Natural voiding
Collection Frequency:Daily
Collection Duration:3 days of each time period
Volumeoramount Collected:1 gm
Storage Conditions:-80℃
Collection Vials:2 mL screw cap polypropylene vials
Storage Vials:2 mL screw cap polypropylene vials
Collection Tube Temp:Room temperature
Additives:None

Treatment:

Treatment ID:TR001034
Treatment Summary:The placebo treatment group was administered Clindamycin orally with a placebo once daily for 21 days with reevaluation 603 days thereafter. The synbiotic treatment group was administered Clindamycin orally with a commercially-available synbiotic (Proviable DC) once daily for 21 days with reevaluation 603 days thereafter.
Treatment Compound:Clindamycin, placebo (Placebo treatment group); Clindamycin, Proviable DC (Synbiotic treatment group)
Treatment Route:PO
Treatment Dose:75 mg, 2 capsules
Treatment Dosevolume:21 days

Sample Preparation:

Sampleprep ID:SP001027
Sampleprep Summary:Samples were immediately frozen and remained in storage at -80ºC pending completion of data collection. Samples for each cat from each timepoint were combined directly prior to sample analysis to generate pooled samples for analysis. Genomic DNA was extracted from 100 mg of feces from each pooled sample using a commercially available kit (PowerSoil®, Mo Bio, Carlsbad, CA USA) according to manufacturer’s protocol. 10 mg of lyophilized feces from each pooled sample were used for metabolomic analyses.
Processing Method:Lyophilization

Combined analysis:

Analysis ID AN001607
Analysis type MS
Chromatography type GC
Chromatography system Leco Pegasus 4D GC
Column Restek Rtx-5Sil (30m x 0.25mm,0.25um)
MS Type EI
MS instrument type GC-TOF
MS instrument name Leco Pegasus III GC TOF
Ion Mode POSITIVE
Units Counts

Chromatography:

Chromatography ID:CH001129
Instrument Name:Leco Pegasus 4D GC
Column Name:Restek Rtx-5Sil (30m x 0.25mm,0.25um)
Column Pressure:7.7 PSI (initial condition)
Column Temperature:50 - 330°C
Flow Rate:1 ml/min
Injection Temperature:50°C ramped to 250°C by 12°C/s
Sample Injection:0.5 uL
Oven Temperature:50°C for 1 min, then ramped at 20°C/min to 330°C, held constant for 5 min
Transferline Temperature:230°C
Washing Buffer:Ethyl Acetate
Sample Loop Size:30 m length x 0.25 mm internal diameter
Randomization Order:Excel generated
Chromatography Type:GC

MS:

MS ID:MS001485
Analysis ID:AN001607
Instrument Name:Leco Pegasus III GC TOF
Instrument Type:GC-TOF
MS Type:EI
Ion Mode:POSITIVE
Ion Source Temperature:250°C
Ionization Energy:70eV
Mass Accuracy:Nominal
Scan Range Moverz:85-500
Scanning Cycle:17 Hz
Scanning Range:80-500 Da
Skimmer Voltage:1850
  logo